This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ragusa, A Articles by Nobili, M Search for Related Content PubMed PubMed Citation Articles by Ragusa, A Articles by Nobili, M Social Bookmarking                         What's this?

Progesterone supplement in pregnancy: an immunologic therapy?

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy, antonio.ragusa{at}ostetriciaitaliana.it

C de Carolis

Center for the Prevention, Diagnosis and Therapy of Recurrent Spontaneous Abortion, ASL Roma C, Rome, Italy

A dal Lago

Center for the Prevention, Diagnosis and Therapy of Recurrent Spontaneous Abortion, ASL Roma C, Rome, Italy

D Miriello

Center for the Prevention, Diagnosis and Therapy of Recurrent Spontaneous Abortion, ASL Roma C, Rome, Italy

G Ruggiero

Center for the Prevention, Diagnosis and Therapy of Recurrent Spontaneous Abortion, ASL Roma C, Rome, Italy

A Brucato

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

M P Pisoni

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

M Muscarà

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

R Merati

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

L Maccario

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

M Nobili

Center for the Prevention, Diagnosis and Therapy of Immunological Diseases in Pregnancy, Niguarda Hospital, Milan, Italy

One of the most interesting functions of the placenta is the regulation of the maternal immune response such that the fetal semi-allograft is tolerated during pregnancy. Trophoblasts are presumed to be essential to this phenomenon because they lie at the maternal-fetal interface, where they are in direct contact with cells of the maternal immune system. Trophoblasts do not express classic major histocompatibility complex (MHC) class II molecules. Surprisingly, cytotrophoblasts express more HLA-G, a MHC class Ib molecule, as they invade the uterus. Progesterone plays an important role in postovulatory regulation of the menstrual cycle. If fertilization occurs, progesterone supports implantation of the ovum and maintains the pregnancy. Progesterone has been named the ‘hormone of pregnancy’, because in preparing the endometrium for embryo implantation and facilitating endometrial development, it is critical to the very survival of a pregnancy. In addition, this key hormone inhibits the rejection of T cell-mediated tissue and also decreases myometrial activity and sensitivity throughout pregnancy. The cellular actions of progesterone are mediated through intracellular progesterone receptors (PRs), which are well studied gene regulators, not express classic major histocompatibility complex. The more used paradigm is relative to the alteration of relationship TH1/TH2, but the complexity of the respective distributions of cytokines at the materno-fetal interface, strongly suggest that, as useful as it certainly was for a while, the Th1/Th2 paradigm must now be considered as an oversimplification. Rather, the existing data point to sequential windows and are suggestive of a system where an extreme complexity is allied to very precise timing and tuning. They also suggest that the materno-fetal relationship is not simply maternal tolerance of a foreign tissue, but a series of intricate mutual cytokine interactions governing selective immune regulation and also control of the adhesion and vascularization processes during this dialogue. However, as shifting the immune response toward the Th2 pattern (IL-4, IL-5, IL-6) may benefit the fetus, whereas development of proinflammatory Th1 cells (secreting IL-2, IFN g, TNF a) may be harmful. Now we are working to open comprise the precise behaviour of NK populations, with the hope of obtaining a diagnostic test of the condition of abortion from ‘immunological causes’.

Key Words: cytokines • immunological • pregnancy • progesterone

Lupus, Vol. 13, No. 9, 639-642 (2004)
DOI: 10.1191/0961203304lu2007oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Maccio, C. Madeddu, E. Sanna, F. Panzone, A. Volpe, and G. Mantovani Evidence that Human Serum with High Levels of Estrogens Interferes with Immune System Both by Decreasing CD25 Expression on T-Cell and by Increasing Interleukin-2 Availability Reproductive Sciences, November 1, 2008; 15(9): 961 - 969. [Abstract] [PDF]

				G. X. Rosario, G. Sachdeva, D. D. Manjramkar, D. N. Modi, P. K. Meherji, and C. P. Puri Endometrial expression of immunomodulatory cytokines and their regulators during early pregnancy in bonnet monkeys (Macaca radiata) Hum. Reprod., November 1, 2005; 20(11): 3039 - 3046. [Abstract] [Full Text] [PDF]